Brain Cancer Molecular Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 94 pages | ID: B1132529746AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Brain Cancer Molecular Diagnostics in Global, including the following market information:

Global Brain Cancer Molecular Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Brain Cancer Molecular Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brain Cancer Molecular Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Brain Cancer Molecular Diagnostics Market Segment Percentages, By Type, 2020 (%)

• PCR
• FISH
• DNA Sequencing
• Gene Chip

China Brain Cancer Molecular Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Brain Cancer Molecular Diagnostics Market Segment Percentages, By Application, 2020 (%)

• Clinical Diagnosis
• Drug Screening
• Research

Global Brain Cancer Molecular Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Brain Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Brain Cancer Molecular Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Brain Cancer Molecular Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Genetronhealth
• Premed
• Gene+
• DMDbiomed
• Helixgen
• Annoroad
• Geneis
• Unitedgene
• Inmedi
• Qiagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brain Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brain Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRAIN CANCER MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Brain Cancer Molecular Diagnostics Market Size: 2021 VS 2027
2.2 Global Brain Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brain Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Brain Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Brain Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Brain Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Brain Cancer Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Brain Cancer Molecular Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 PCR
  4.1.3 FISH
  4.1.4 DNA Sequencing
  4.1.5 Gene Chip
4.2 By Type - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Brain Cancer Molecular Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Brain Cancer Molecular Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brain Cancer Molecular Diagnostics Market Size, 2021 & 2027
  5.1.2 Clinical Diagnosis
  5.1.3 Drug Screening
  5.1.4 Research
5.2 By Application - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Brain Cancer Molecular Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Brain Cancer Molecular Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Brain Cancer Molecular Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Brain Cancer Molecular Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Brain Cancer Molecular Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Brain Cancer Molecular Diagnostics Revenue, 2016-2027
  6.3.2 US Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.3 Canada Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Brain Cancer Molecular Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Brain Cancer Molecular Diagnostics Revenue, 2016-2027
  6.4.2 Germany Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.3 France Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.5 Italy Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.6 Russia Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Brain Cancer Molecular Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Brain Cancer Molecular Diagnostics Revenue, 2016-2027
  6.5.2 China Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.3 Japan Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.5.6 India Brain Cancer Molecular Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Brain Cancer Molecular Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Brain Cancer Molecular Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.3 Israel Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Brain Cancer Molecular Diagnostics Market Size, 2016-2027
  6.7.5 UAE Brain Cancer Molecular Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Genetronhealth
  7.1.1 Genetronhealth Corporate Summary
  7.1.2 Genetronhealth Business Overview
  7.1.3 Genetronhealth Brain Cancer Molecular Diagnostics Major Product Offerings
  7.1.4 Genetronhealth Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.1.5 Genetronhealth Key News
7.2 Premed
  7.2.1 Premed Corporate Summary
  7.2.2 Premed Business Overview
  7.2.3 Premed Brain Cancer Molecular Diagnostics Major Product Offerings
  7.2.4 Premed Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.2.5 Premed Key News
7.3 Gene+
  7.3.1 Gene+ Corporate Summary
  7.3.2 Gene+ Business Overview
  7.3.3 Gene+ Brain Cancer Molecular Diagnostics Major Product Offerings
  7.3.4 Gene+ Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.3.5 Gene+ Key News
7.4 DMDbiomed
  7.4.1 DMDbiomed Corporate Summary
  7.4.2 DMDbiomed Business Overview
  7.4.3 DMDbiomed Brain Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 DMDbiomed Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.4.5 DMDbiomed Key News
7.5 Helixgen
  7.5.1 Helixgen Corporate Summary
  7.5.2 Helixgen Business Overview
  7.5.3 Helixgen Brain Cancer Molecular Diagnostics Major Product Offerings
  7.5.4 Helixgen Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.5.5 Helixgen Key News
7.6 Annoroad
  7.6.1 Annoroad Corporate Summary
  7.6.2 Annoroad Business Overview
  7.6.3 Annoroad Brain Cancer Molecular Diagnostics Major Product Offerings
  7.6.4 Annoroad Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.6.5 Annoroad Key News
7.7 Geneis
  7.7.1 Geneis Corporate Summary
  7.7.2 Geneis Business Overview
  7.7.3 Geneis Brain Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Geneis Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.7.5 Geneis Key News
7.8 Unitedgene
  7.8.1 Unitedgene Corporate Summary
  7.8.2 Unitedgene Business Overview
  7.8.3 Unitedgene Brain Cancer Molecular Diagnostics Major Product Offerings
  7.8.4 Unitedgene Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.8.5 Unitedgene Key News
7.9 Inmedi
  7.9.1 Inmedi Corporate Summary
  7.9.2 Inmedi Business Overview
  7.9.3 Inmedi Brain Cancer Molecular Diagnostics Major Product Offerings
  7.9.4 Inmedi Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.9.5 Inmedi Key News
7.10 Qiagen
  7.10.1 Qiagen Corporate Summary
  7.10.2 Qiagen Business Overview
  7.10.3 Qiagen Brain Cancer Molecular Diagnostics Major Product Offerings
  7.10.4 Qiagen Brain Cancer Molecular Diagnostics Revenue in Global (2016-2021)
  7.10.5 Qiagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brain Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Brain Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Molecular Diagnostics in Global Market
Table 5. Top Brain Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Brain Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Brain Cancer Molecular Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Brain Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Brain Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Brain Cancer Molecular Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Brain Cancer Molecular Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Genetronhealth Corporate Summary
Table 31. Genetronhealth Brain Cancer Molecular Diagnostics Product Offerings
Table 32. Genetronhealth Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Premed Corporate Summary
Table 34. Premed Brain Cancer Molecular Diagnostics Product Offerings
Table 35. Premed Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Gene+ Corporate Summary
Table 37. Gene+ Brain Cancer Molecular Diagnostics Product Offerings
Table 38. Gene+ Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. DMDbiomed Corporate Summary
Table 40. DMDbiomed Brain Cancer Molecular Diagnostics Product Offerings
Table 41. DMDbiomed Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Helixgen Corporate Summary
Table 43. Helixgen Brain Cancer Molecular Diagnostics Product Offerings
Table 44. Helixgen Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. Annoroad Corporate Summary
Table 46. Annoroad Brain Cancer Molecular Diagnostics Product Offerings
Table 47. Annoroad Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. Geneis Corporate Summary
Table 49. Geneis Brain Cancer Molecular Diagnostics Product Offerings
Table 50. Geneis Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. Unitedgene Corporate Summary
Table 52. Unitedgene Brain Cancer Molecular Diagnostics Product Offerings
Table 53. Unitedgene Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Inmedi Corporate Summary
Table 55. Inmedi Brain Cancer Molecular Diagnostics Product Offerings
Table 56. Inmedi Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Brain Cancer Molecular Diagnostics Product Offerings
Table 59. Qiagen Brain Cancer Molecular Diagnostics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Brain Cancer Molecular Diagnostics Segment by Type
Figure 2. Brain Cancer Molecular Diagnostics Segment by Application
Figure 3. Global Brain Cancer Molecular Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Molecular Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Brain Cancer Molecular Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Molecular Diagnostics Revenue in 2020
Figure 8. By Type - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Genetronhealth Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Premed Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Gene+ Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. DMDbiomed Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Helixgen Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Annoroad Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Geneis Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Unitedgene Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Inmedi Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)